The DOI matches its Crossref record; 97 of the 99 references it cites were found in a registry or an index.
Enzyme-responsive nanoparticles for drug release and diagnostics
Abstract
Enzymes are key components of the bionanotechnology toolbox that possess exceptional biorecognition capabilities and outstanding catalytic properties. When combined with the unique physical properties of nanomaterials, the resulting enzyme-responsive nanoparticles can be designed to perform functions efficiently and with high specificity for the triggering stimulus. This powerful concept has been successfully applied to the fabrication of drug delivery schemes where the tissue of interest is targeted via release of cargo triggered by the biocatalytic action of an enzyme. Moreover, the chemical transformation of the carrier by the enzyme can also generate therapeutic molecules, therefore paving the way to design multimodal nanomedicines with synergistic effects. Dysregulation of enzymatic activity has been observed in a number of severe pathological conditions, and this observation is useful not only to program drug delivery in vivo but also to fabricate ultrasensitive sensors for diagnosing these diseases. In this review, several enzyme-responsive nanomaterials such as polymer-based nanoparticles, liposomes, gold nanoparticles and quantum dots are introduced, and the modulation of their physicochemical properties by enzymatic activity emphasized. When known, toxicological issues related to the utilization nanomaterials are highlighted. Key examples of enzyme-responsive nanomaterials for drug delivery and diagnostics are presented, classified by the type of effector biomolecule, including hydrolases such as proteases, lipases and glycosidases, and oxidoreductases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most advanced of these are lipid-based NPs (liposomes and SLNs), which have proven biocompatibility and the ability to carry both hydrophilic and hydrophobic drugs. However, their clinical application has been hindered by rapid clearance via the reticuloendothelial system (RES) and stability issues, resulting in some trial failures [9, 100].”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [100]
In the citing paper
“Polymeric NPs offer the advantages of controlled drug release and modifiable surface properties that enhance targeting and circulation time. However, concerns about polymer degradation, toxicity, and inconsistent BBB penetration limit their clinical application, despite some encouraging preclinical data [100, 155].”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [100]
In the citing paper
“While some trials have demonstrated the safety and feasibility of these therapies, many face challenges relating to therapeutic efficacy, pharmacokinetics, and long-term safety. This has led to the discontinuation of some trials or slow progression.”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [100]
In the citing paper
“Despite promising preclinical results, the clinical translation of nanomedicine-based AD therapies remains in its early stages. Only a few NP formulations have entered clinical trials, with the main focus being on improving drug delivery across the BBB and targeting Aβ or tau pathology.”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [100]
In the citing paper
“The development of enzyme-responsive nanoparticles for targeted therapy of tumor microenvironment is another effective strategy for nanoparticle intelligence which could release the payload into the desired target.143”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [143]
Citations
Cites
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Nanostructured materials for advanced energy conversion and storage devices
Aricò, A. S., Bruce, P. G., Scrosati, B., Tarascon, J., & van Schalkwijk, W. (2005) · Nature Materials · doi:10.1038/nmat1368 · Cited by 8,876
Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic Detection
Chan, W. C. W., & Nie, S. (1998) · Science · doi:10.1126/science.281.5385.2016 · Cited by 7,284
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Quantum dot bioconjugates for imaging, labelling and sensing
Medintz, I. L., Uyeda, H. T., Goldman, E. R., & Mattoussi, H. M. (2005) · Nature Materials · doi:10.1038/nmat1390 · Cited by 6,236
Localized Surface Plasmon Resonance Spectroscopy and Sensing
Willets, K. A., & Duyne, R. P. V. (2006) · Annual Review of Physical Chemistry · doi:10.1146/annurev.physchem.58.032806.104607 · Cited by 6,162
In vivo cancer targeting and imaging with semiconductor quantum dots
Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. K., & Nie, S. (2004) · Nature Biotechnology · doi:10.1038/nbt994 · Cited by 4,775
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Dabbousi, B. O., Rodriguez-Viejo, J., Mikulec, F. V., Heine, J. R., Mattoussi, H., Ober, R., Jensen, K. F., & Bawendi, M. G. (1997) · The Journal of Physical Chemistry B · doi:10.1021/jp971091y · Cited by 4,229
Flagged first, then by citations
2 of the 99 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Kurtzberg, 1988, A phase II study of polyethylene glycol (PEG) conjugated l-asparaginase in patients with refractory acute leukaemias, Proc. Am. Assoc. Cancer Res., 29, 213
Cited by
Sorted by citations
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic‐Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,774
Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems
Karimi, M., Ghasemi, A., Zangabad, P. S., Rahighi, R., Basri, S. M. M., Mirshekari, H., Amiri, M., Shafaei, Z., Aslani, A., Bozorgomid, M., et al. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00798d · Cited by 1,557
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,279
Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073
“143 The following will exhibit several typical enzymes used in enzyme-response smart nano-therapeutic strategies.”
BackgroundThe Smart Drug Delivery System and Its Clinical Potential
Liu, D., Yang, F., Xiong, F., & Gu, N. (2016) · Theranostics · doi:10.7150/thno.14858 · Cited by 1,066
“Since enzymes (such as glycosidases, lipase, phospoholipases or proteases) are related to almost all the biological and metabolic process, they can be exploited to achieve enzyme-mediated drug release by the bio-catalytic action at the cancer or inflammation tissues [38].”
BackgroundDai, Y., Xu, C., Sun, X., & Chen, X. S. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00592f · Cited by 939
Ge, Z., & Liu, S. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60048c · Cited by 924
Gold Nanoparticles for In Vitro Diagnostics
Zhou, W. J., Gao, X., Liu, D., & Chen, X. S. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00100 · Cited by 911
Advances in Biomaterials for Drug Delivery
Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J., & Langer, R. (2018) · Advanced Materials · doi:10.1002/adma.201705328 · Cited by 890
Strategies for advancing cancer nanomedicine
Chauhan, V. P., & Jain, R. K. (2013) · Nature Materials · doi:10.1038/nmat3792 · Cited by 821
Supramolecular self-assemblies as functional nanomaterials
Busseron, E., Ruff, Y., Moulin, É., & Giuseppone, N. (2013) · Nanoscale · doi:10.1039/c3nr02176a · Cited by 713
Enzyme-responsive nanomaterials for controlled drug delivery
Hu, Q., Katti, P. S., & Gu, Z. (2014) · Nanoscale · doi:10.1039/c4nr04249b · Cited by 683
Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis
Das, S. S., Bharadwaj, P., Bilal, M., Barani, M., Rahdar, A., Taboada, P., BUNGAU, S. G., & Kyzas, G. Z. (2020) · Polymers · doi:10.3390/polym12061397 · Cited by 615
A Review on the Synthesis and Functionalization of Gold Nanoparticles as a Drug Delivery Vehicle
Amina, S. J., & Guo, B. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s279094 · Cited by 612
“They are substrate specific and not only increase the speed of chemical reactions but also control specificity of metabolic processes.(302) The characteristic degradation by enzyme can be employed for the selective and controlled release of therapeutics from gold nano-conjugates through enhanced permeability and reten…”
BackgroundStimuli-Responsive Nanomaterials for Biomedical Applications
Blum, A. P., Kammeyer, J. K., Rush, A. M., Callmann, C. E., Hahn, M. E., & Gianneschi, N. C. (2014) · Journal of the American Chemical Society · doi:10.1021/ja510147n · Cited by 548
Peptide–drug conjugates as effective prodrug strategies for targeted delivery
Wang, Y., Cheetham, A. G., Angacian, G., Su, H., Xie, L., & Cui, H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.015 · Cited by 516
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
Vallet‐Regí, M., Schüth, F., Lozano, D., Colilla, M., & Manzano, M. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00659b · Cited by 537
Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine
Adir, O., Poley, M., Chen, G., Froim, S., Krinsky, N., Shklover, J., Shainsky‐Roitman, J., Lammers, T., & Schroeder, A. (2020) · Advanced Materials · doi:10.1002/adma.201901989 · Cited by 496
Gated Materials for On-Command Release of Guest Molecules
Aznar, E., Oroval, M., Pascual, L., Murguía, J. R., Martínez‐Máñez, R., & Sancenón, F. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00456 · Cited by 497
Wankar, J., Kotla, N. G., Gera, S., Rasala, S., Pandit, A. S., & Rochev, Y. A. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909049 · Cited by 486
He, Q., & Shi, J. (2013) · Advanced Materials · doi:10.1002/adma.201303123 · Cited by 482
Multifunctional polymeric micelles for delivery of drugs and siRNA
Jhaveri, A. M., & Torchilin, V. P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00077 · Cited by 466
“Another option is to modify the micelle surface with peptides or oligonucleotides that can cause physical changes in the micelles upon enzymatic transformation (De La Rica et al., 2012; Hu et al., 2012).”
BackgroundChemophototherapy: An Emerging Treatment Option for Solid Tumors
Luo, D., Carter, K. A., Miranda, D., & Lovell, J. F. (2016) · Advanced Science · doi:10.1002/advs.201600106 · Cited by 441
Stimuli-responsive nanomaterials for therapeutic protein delivery
Lu, Y., Sun, W., & Gu, Z. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.015 · Cited by 415
“Enzymes play a central role in biochemical processes, and therefore are important targets for drug development [52].”
BackgroundAdvanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment
Zhang, M., Hu, W., Cai, C., Wu, Y. Q., Li, J., & Dong, S. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100223 · Cited by 405
Development of endogenous enzyme-responsive nanomaterials for theranostics
Mu, J., Lin, J., Huang, P., & Chen, X. S. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00663b · Cited by 394
Polymer vesicles: Mechanism, preparation, application, and responsive behavior
Zhu, Y., Yang, B., Chen, S., & Du, J. (2016) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2015.05.001 · Cited by 396
Stimuli-responsive nanoparticles for targeting the tumor microenvironment
Du, J., Lane, L. A., & Nie, S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.050 · Cited by 395
“It is well known that the tumor microenvironment has unique physiological characteristics such as acidic pH [17], hypoxia [18], and up-regulation of certain enzymes [19].”
BackgroundTumor microenvironment and intracellular signal-activated nanomaterials for anticancer drug delivery
Mo, R., & Gu, Z. (2015) · Materials Today · doi:10.1016/j.mattod.2015.11.025 · Cited by 386
Ramasamy, T., Ruttala, H. B., Gupta, B., Poudel, B. K., Choi, H., Yong, C. S., & Kim, J. O. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.043 · Cited by 374
“surface of tumor cells, which is believed to facilitate tumor extravasation and metastasization, establishing them as major elements of tumor progression [240].”
BackgroundNanotechnology-based approaches in anticancer research
Kamal, M. A., Jabir, N. R., Tabrez, S. S. M., Ashraf, Shakil, S., & Damanhouri (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s33838 · Cited by 361
Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery
Majumder, J., & Minko, T. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1828339 · Cited by 353
Stimuli-Responsive Drug Release from Smart Polymers
Wells, C. M., Harris, M. A., Choi, L. R., Murali, V. P., Guerra, F. D., & Jennings, J. A. (2019) · Journal of Functional Biomaterials · doi:10.3390/jfb10030034 · Cited by 350
Yao, C., Wang, P., Li, X., Hu, X., Hou, J., Wang, L., & Zhang, F. (2016) · Advanced Materials · doi:10.1002/adma.201503799 · Cited by 344
Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment
Chen, B., Dai, W., He, B., Zhang, H., Wang, X., Wang, Y., & Zhang, Q. (2017) · Theranostics · doi:10.7150/thno.16684 · Cited by 350
“The stimuli of Ms-DDS can mainly be divided into two classes: 1) the extracorporeal physical stimuli, such as the magnetic-responsive superparamagnetic iron oxide-based nanoparticles [9, 10] and external light[11], thermo- [12] or ultrasound-sensitive drug delivery systems [13]; 2) the endogenous tumor microenvironmen…”
BackgroundUnderstanding nanoparticle cellular entry: A physicochemical perspective
Beddoes, C. M., Case, C. P., & Briscoe, W. H. (2015) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2015.01.007 · Cited by 347
Stimuli-sensitive nanopreparations for combination cancer therapy
Jhaveri, A. M., Deshpande, P. P., & Torchilin, V. P. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.002 · Cited by 338
Stimuli‐responsive nanotherapeutics for precision drug delivery and cancer therapy
Qiao, Y., Wan, J., Zhou, L., Ma, W., Yang, Y., Luo, W., Yu, Z., & Wang, H. (2019) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1527 · Cited by 332
Yang, G., Phua, S. Z. F., Lim, W. Q., Zhang, R., Feng, L., Liu, G., Wu, H., Bindra, A. K., Jana, D., Liu, Z., et al. (2019) · Advanced Materials · doi:10.1002/adma.201901513 · Cited by 333
Near-infrared photoactivated nanomedicines for photothermal synergistic cancer therapy
Sun, H., Zhang, Q., Li, J., Peng, S., Wang, X., & Cai, R. (2021) · Nano Today · doi:10.1016/j.nantod.2020.101073 · Cited by 336
Rahim, M. A., Jan, N., Khan, S., Shah, H., Madni, A., Khan, A., Jabar, A., Khan, S., Elhissi, A. M. A., Hussain, Z., et al. (2021) · Cancers · doi:10.3390/cancers13040670 · Cited by 342
“The enzyme-responsive nanomaterial has led to growing interest in biological applications such as therapeutics and diagnostics which may either be due to its predictable chemical composition as a biocatalyst or by modification in enzymatic reactions [163].”
BackgroundProgress, challenges, and future of nanomedicine
Zhang, C., Yan, L., Wang, X., Zhu, S., Chen, C., Gu, Z., & Zhao, Y. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101008 · Cited by 331
De, R., Mahata, M. K., & Kim, K. (2022) · Advanced Science · doi:10.1002/advs.202105373 · Cited by 316
Inorganic nanoparticles engineered to attack bacteria
Miller, K. P., Wang, L., Benicewicz, B. C., & Decho, A. W. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00041f · Cited by 291
Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery
Amreddy, N., Babu, A., Muralidharan, R., Panneerselvam, J., Srivastava, A., Ahmed, R. A., Mehta, M., Munshi, A., & Ramesh, R. (2017) · Advances in cancer research · doi:10.1016/bs.acr.2017.11.003 · Cited by 297
Perspectives on the past, present, and future of cancer nanomedicine
Youn, Y. S., & Bae, Y. H. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.05.008 · Cited by 288
Enzyme‐Responsive Polymeric Vesicles for Bacterial‐Strain‐Selective Delivery of Antimicrobial Agents
Li, Y., Liu, G., Wang, X., Hu, J., & Liu, S. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201509401 · Cited by 273
Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery
Baeza, A., Colilla, M., & Vallet‐Regí, M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.953051 · Cited by 274
“3 Enzymes Some pathologies course with significant overexpression of certain enzymes and this fact can be used for triggering the drug release [106].”
BackgroundCancer nanotechnology: current status and perspectives
Kemp, J. A., & Kwon, Y. J. (2021) · Nano Convergence · doi:10.1186/s40580-021-00282-7 · Cited by 290
Song, Y., Li, Y., Xu, Q., & Liu, Z. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s117495 · Cited by 262
Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems
Su, S., & Kang, P. M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090837 · Cited by 269
Nanobiocatalyst advancements and bioprocessing applications
Misson, M., Zhang, H., & Jin, B. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0891 · Cited by 258
Drug delivery vehicles on a nano-engineering perspective
Felice, B., Prabhakaran, M. P., Rodríguez, A. P., & Ramakrishna, S. (2014) · Materials Science and Engineering C · doi:10.1016/j.msec.2014.04.049 · Cited by 260
Nanomedicines for renal disease: current status and future applications
Kamaly, N., He, C., Ausiello, D. A., & Farokhzad, O. C. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.156 · Cited by 256
Enzyme-Responsive Nanoparticles for Anti-tumor Drug Delivery
Li, M., Zhao, G., Su, W.-K., & Shuai, Q. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00647 · Cited by 253
“Moreover, enzymes, as triggers, have many advantages, including high chemical selectivity and substrate specificity (de la Rica et al., 2012), and usually enzyme-catalyzed reactions proceed efficiently under mild conditions (low temperature, aqueous media, neutral or close to neutral pH) (Ulijn,…”
BackgroundSynthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications
Mosayebi, J., Kiyasatfar, M., & Laurent, S. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700306 · Cited by 250
Co-delivery of chemotherapeutics and proteins for synergistic therapy
He, C., Tang, Z., Tian, H., & Chen, X. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.021 · Cited by 231
Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications
Uthaman, S., Huh, K. M., & Park, I. (2018) · Biomaterials Research · doi:10.1186/s40824-018-0132-z · Cited by 232
Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release
Luo, D., Carter, K. A., Razi, A., Geng, J., Shao, S., Giraldo, D., Sunar, U., Ortega, J., & Lovell, J. F. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.027 · Cited by 223
Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer.
Li, T.-T., Shi, S.-X., Goel, S., Shen, X., Xie, X., Chen, Z., Zhang, H.-X., Li, S., Qin, X., Yang, H., et al. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.02.031 · Cited by 204
Interfacing Materials Science and Biology for Drug Carrier Design
Such, G. K., Yan, Y., Johnston, A. P. R., Gunawan, S. T., & Caruso, F. (2015) · Advanced Materials · doi:10.1002/adma.201405084 · Cited by 220
Recent advances and remaining challenges for polymeric nanocomposites in healthcare applications
Kumar, S., Sarita, S., Nehra, M., Dilbaghi, N., Tankeshwar, K., & Kim, K. (2018) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2018.03.001 · Cited by 220
Dynamic Nanoparticle Assemblies for Biomedical Applications
Li, F., Lu, J., Kong, X., Hyeon, T., & Ling, D. (2017) · Advanced Materials · doi:10.1002/adma.201605897 · Cited by 215
Molecular Communication and Nanonetwork for Targeted Drug Delivery: A Survey
Chude-Okonkwo, U. A. K., Malekian, R., Maharaj, B. T., & Vasilakos, A. V. (2017) · IEEE Communications Surveys & Tutorials · doi:10.1109/comst.2017.2705740 · Cited by 216
“More also, the diagnostic capability of nanoparticles [71] can”
BackgroundRecent advances of two-dimensional materials in smart drug delivery nano-systems
Zhang, H., Fan, T., Chen, W., Li, Y., & Wang, B. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.06.012 · Cited by 205
Physical stimuli-responsive vesicles in drug delivery: Beyond liposomes and polymersomes
Kauscher, U., Holme, M. N., Björnmalm, M., & Stevens, M. M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.012 · Cited by 202
“Nanomaterials that react upon endogenous triggers take advantage of the physiological differences between diseased and healthy tissue, such as chemical differences including pH [15], hypoxia [16, 17], redox [18] or enzymes [19, 20], and physical differences including mechanical triggers [21] such as shear stress-media…”
Self-citationEnzyme-responsive polymer hydrogels for therapeutic delivery
Chandrawati, R. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216647186 · Cited by 200
“Stimuli-responsive polymeric materials have emerged as powerful tools and play an increasingly important role in a wide range of biomedical applications, including drug delivery,(1,2) tissue engineering,(3,4) bioimaging,(5,6) and biosensing.(7,8) These materials can be finely tuned to exhibit (ir)reversible changes in…”
BackgroundStimuli-responsive nano-assemblies for remotely controlled drug delivery
Li, F., Qin, Y., Lee, J., Liao, H., Wang, N., Davis, T. P., Qiao, R., & Ling, D. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.051 · Cited by 201
(Macro)molecular self-assembly for hydrogel drug delivery
Webber, M. J., & Pashuck, E. T. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.006 · Cited by 204
Wu, J., Zhao, L., Xu, X., Bertrand, N., Choi, W. I., Yameen, B., Shi, J., Shah, V., Mulvale, M., MacLean, J. L., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201503863 · Cited by 193
Song, Z., Wu, Y., Cao, Q., Wang, H., Wang, X., & Han, H. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201800011 · Cited by 190
Biomedical applications of the graphene-based materials
Zhang, B., Wang, Y., & Zhai, G. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.12.073 · Cited by 191
Kong, F., Liang, Z., Luan, D., Liu, X., Xu, K., & Tang, B. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b01135 · Cited by 189
Ooi, H. W., Hafeez, S., van Blitterswijk, C., Moroni, L., & Baker, M. B. (2017) · Materials Horizons · doi:10.1039/c7mh00373k · Cited by 192
Stimuli-responsive prodrug-based cancer nanomedicine
Xie, A., Hanif, S., Ouyang, J., Tang, Z., Kong, N., Kim, N. Y., Qi, B., Patel, D. N., Shi, B., & Tao, W. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102821 · Cited by 193
Novel delivery approaches for cancer therapeutics
Mitra, A. K., Agrahari, V., Mandal, A., Cholkar, K., Natarajan, C., Shah, S. J., Joseph, M. A., Trinh, H. M., Vaishya, R., Yang, X., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.067 · Cited by 186
Zhang, C., Pan, D., Li, J., Hu, J., Bains, A., Guys, N., Zhu, H., Li, X., Luo, K., Gong, Q., et al. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.02.047 · Cited by 181
Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms
Kaushik, N., Borkar, S. B., Nandanwar, S., Panda, P. K., Choi, E. H., & Kaushik, N. K. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01364-2 · Cited by 190
Chen, H., Zeng, X., Tham, H. P., Phua, S. Z. F., Cheng, W., Zeng, W., Shi, H., Mei, L., & Zhao, Y. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201900886 · Cited by 180
Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs
Fouladi, F., Steffen, K. J., & Mallik, S. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00736 · Cited by 178
Targeted Delivery Methods for Anticancer Drugs
Veselov, V. V., Nosyrev, A. E., Jicsinszky, L., Alyautdin, R. N., & Cravotto, G. (2022) · Cancers · doi:10.3390/cancers14030622 · Cited by 184
Stimuli‐Responsive Polymeric Nanoparticles for Nanomedicine
Crucho, C. I. C. (2014) · ChemMedChem · doi:10.1002/cmdc.201402290 · Cited by 180
Construction of multifunctional wound dressings with their application in chronic wound treatment
Long, L., Liu, W., Hu, C., Li, Y., & Wang, Y. (2022) · Biomaterials Science · doi:10.1039/d2bm00620k · Cited by 173
Carnovale, C., Bryant, G., Shukla, R., & Bansal, V. (2016) · Progress in Materials Science · doi:10.1016/j.pmatsci.2016.04.003 · Cited by 175
Stimuli‐responsive crosslinked nanomedicine for cancer treatment
Xue, X., Qu, H., & Li, Y. (2022) · Exploration · doi:10.1002/exp.20210134 · Cited by 169
Activatable fluorescent probes for real-time imaging-guided tumor therapy
Duan, Q.-J., Zhao, Z., Zhang, Y., Fu, L., Yuan, Y., Du, J., & Wang, J. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114793 · Cited by 168
Zhang, C., Pan, D., Luo, K., She, W., Guo, C., Yang, Y., & Gu, Z. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300601 · Cited by 163
Programming Stimuli-Responsive Behavior into Biomaterials
Badeau, B. A., & DeForest, C. A. (2019) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-060418-052324 · Cited by 169
“Common enzymatic classes exploited in stimuli-responsive biomaterials are proteases, lipidases, and oxidoreductases (25, 26), which respectively cleave proteins, cleave lipids, and catalyze electron transfer.”
BackgroundYang, G., Sun, X., Liu, J., Feng, L., & Liu, Z. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201600722 · Cited by 163
Peptide-based nanoprobes for molecular imaging and disease diagnostics
Zhang, P., Cui, Y., Anderson, C. F., Zhang, C., Li, Y., Wang, R., & Cui, H. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00793k · Cited by 160
pH-sensitive drug-delivery Systems for Tumor Targeting
He, X., Li, J., An, S., & Jiang, C. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.120 · Cited by 160
Shreffler, J., Pullan, J. E., Dailey, K. M., Mallik, S., & Brooks, A. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236056 · Cited by 167
Shim, M. K., Yang, S., Sun, I., & Kim, K. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114177 · Cited by 158
Zhao, X., Liu, L., Li, X., Zeng, J., Jia, X., & Liu, P. (2014) · Langmuir · doi:10.1021/la502952f · Cited by 152
Yao, C., Li, Y., Wang, Z., Song, C., Hu, X., & Liu, S. (2020) · ACS Nano · doi:10.1021/acsnano.9b08285 · Cited by 149
Surface modification of lipid-based nanocarriers for cancer cell-specific drug targeting
Kim, C. H., Lee, S. G., Kang, M. J., Lee, S. K., & Choi, Y. W. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0329-5 · Cited by 144
Mesoporous‐Silica‐Functionalized Nanoparticles for Drug Delivery
Giret, S., Man, M. W. C., & Carcel, C. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201500578 · Cited by 146
Metadata
- Authors
- de la Rica, R., Aili, D., & Stevens, M. M.
- Affiliations
- Nanyang Technological University (SG)
- Imperial College London (GB)
- Corresponding author
- Stevens, Molly M.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 64
- Issue
- 11
- Pages
- 967-978
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2162750459
- Cited by
- 765
- References
- 99
- Citations by year
- 2026: 42 · 2025: 57 · 2024: 52 · 2023: 48 · 2022: 60 · 2021: 56 · 2020: 65 · 2019: 68 · 2018: 59 · 2017: 64 · 2016: 53 · 2015: 62 · 2014: 45 · 2013: 24 · 2012: 10
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Advanced Drug Delivery Reviews (publishedVersion)
- PubMed (publishedVersion)
- Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (acceptedVersion)
- DR-NTU (Nanyang Technological University) (submittedVersion)
- Funders
- Engineering and Physical Sciences Research Council (EP/J013331/1)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Keywords
- enzyme-responsive nanoparticles, stimuli-responsive drug delivery, enzyme-responsive drug release, nanomedicine, ultrasensitive biosensor, polymeric nanoparticles, liposomes, gold nanoparticles, quantum dots, proteolytic enzymes, lipase, glycoside hydrolases, oxidative enzymes, nanomaterial toxicity
- MeSH terms
- Diagnostic Imaging, Pharmaceutical Preparations, Hydrolases, Drug Delivery Systems, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
